Abstract
Although not all centres still agree, histological evaluation of liver graft quality is crucial for the short-term outcome of orthotopic liver transplantation (OLT). Pre-transplant and “time zero” biopsies are useful for the assessment of macrovesicular steatosis, i.e. the histological alteration universally accepted as the major cause of early graft failure. Donor biopsies also provide information on graft preservation, fibrosis, and the occurrence of disregarded hepatitis or focal lesions.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Fiorentino M, Vasuri F, Ravaioli M, Ridolfi L, Grigioni WF, Pinna AD, D’Errico-Grigioni A. Predictive value of frozen-section analysis in the histological assessment of steatosis before liver transplantation. Liver Transpl. 2009;15:1821–5.
Lo IJ, Lefkowitch JH, Feirt N, Alkofer B, Kin C, Samstein B, et al. Utility of liver allograft biopsy obtained at procurement. Liver Transpl. 2008;14:639–46.
Selzner M, Clavien PA. Fatty liver in liver transplantation and surgery. Semin Liver Dis. 2001;21:105–13.
Verran D, Kusyk T, Painter D, Fisher J, Koorey D, Strasser S, et al. Clinical experience gained from the use of 120 steatotic donor livers for orthotopic liver transplantation. Liver Transpl. 2003;9:500–5.
Kootstra G, Kievit J, Nederstigt A. Organ donors: heartbeating and non-heartbeating. World J Surg. 2002;26:181–4.
Selzner N, Rudiger H, Graf R, Clavien PA. Protective strategies against ischemic injury of the liver. Gastroenterology. 2003;125:917–36.
Kukan M, Haddad PS. Role of hepatocytes and bile duct cells in preservation-reperfusion injury of the liver grafts. Liver Transpl. 2001;7:381–400.
Kakizoe S, Yanaga K, Starzl TE, Demetris AJ. Evaluation of protocol before transplantation and after reperfusion biopsies from human orthotopic liver allografts: considerations of preservation and early immunological injury. Hepatology. 1990;11:932–41.
Adeyi O, Fischer SE, Guindi M. Liver allograft pathology: approach to interpretation of needle biopsies with clinicopathological correlation. J Clin Pathol. 2010;63:47–74.
Silva MA, Mirza DF, Murphy N, Richards DA, Reynolds GM, Wigmore SJ, Neil DA. Intrahepatic complement activation, sinusoidal endothelial injury, and lactic acidosis are associated with initial poor function of the liver after transplantation. Transplantation. 2008;85:718–25.
Demetris AJ, Kelly DM, Eghtesad B, Fontes P, Wallis Marsh J, Tom K, Tan HP, Shaw-Stiffel T, Boig L, Novelli P, Planinsic R, Fung JJ, Marcos A. Pathophysiologic observations and histopathologic recognition of the portal hyperperfusion or small-for-size syndrome. Am J Surg Pathol. 2006;30:986–93.
Odze R, Goldblum JR. Surgical pathology of the G.I. tract, liver, biliary tract, and pancreas. 2nd ed. Philadelphia: Elsevier; 2009.
Sanchez-Urdazpal L, Gores GJ, Ward EM, Maus TP, Buckel EG, Steers JL, Wiesner RH, Krom RA. Diagnostic features and clinical outcome of ischemic-type biliary complications after liver transplantation. Hepatology. 1993;17:605–9.
Aguilera I, Sousa JM, Gavilan F, et al. Complement component 4d immunostaining in liver allografts of patients with de novo immune hepatitis. Liver Transplant. 2011;17:779–88. Banff schema for grading liver allograft rejection: an international consensus document. Hepatology. 1997;25:658–63.
Scholz M, Auth MK, Markus BH. The immunological role of biliary epithelial cells in human liver transplant rejection. Transpl Immunol. 1997;5:142–51.
Ludwig J, Batts KP, Ploch M, Rakela J, Perkins JD, Wiesner RH. Endothelialitis in hepatic allografts. Mayo Clin Proc. 1989;64:545–54.
Yeh MM, Larson AM, Tung BY, Swanson PE, Upton MP. Endotheliitis in chronic viral hepatitis: a comparison with acute cellular rejection and non-alcoholic steatohepatitis. Am J Surg Pathol. 2006;30:727–33.
Demetris AJ, Sebagh M. Plasma cell hepatitis in liver allografts: variant of rejection or autoimmune hepatitis? Liver Transpl. 2008;14:750–5.
Demetris AJ, Jaffe R, Tsakis A, Ramsey G, Todo S, Belle S, Esquivel C, Shapiro R, Markus B, Mroczeck E, Van Thiel DH, Sysyn G, Gordon R, Makowka L, Starzl T. Antibody-mediated rejection of human orthotopic liver allografts. A study of liver transplantation across AB0 blood group barriers. Am J Pathol. 1988;132:489–502.
Haga H, Egawa H, Fujimoto Y, et al. acute humoral rejection and C4d immunostaining in AB0 blood type-incompatible liver transplantation. Liver Transpl. 2006;12:457–64.
Kozlowski T, Rubinas T, Nickeleit V, et al. Liver allograft antibody-mediated rejection with demonstration of sinusoidal C4d staining and circulating donor specific antibodies. Liver Transpl. 2011;17:357–68.
Hubscher SG. Transplantation pathology. Semin Liver Dis. 2009;29:74–90.
Nakazawa Y, Jonsson JR, Walker NI, et al. Fibrous obliterative lesions of veins contribute to progressive fibrosis in chronic liver allograft rejection. Hepatology. 2000;32:1240–7.
Demetris AJ. Distinguishing between recurrent primary sclerosing cholangitis and chronic rejection. Liver Transpl. 2006;12:S68–72.
Demetris AJ. Evolution of hepatitis C virus in liver allografts. Liver Transpl. 2009;15:S35–41.
Vasuri F, Malvi D, Gruppioni E, Grigioni WF, D’Errico-Grigioni A. Histopathological evaluation of recurrent hepatitis C after liver transplantation: a review. World J Gastroenterol. 2014;20:2810–24.
Gottschlich MJ, Aardema KL, Burd EM, Nakhleh RE, Brown KA, Abouljoud MS, Hirst K, Moonka DK. The use of hepatitis C viral RNA levels in liver tissue to distinguish rejection from recurrent hepatitis C. Liver Transpl. 2001;7:436–41.
D’Errico-Grigioni A, Fiorentino M, Vasuri F, Gruppioni E, Fabbrizio B, Zucchini N, Ballardini G, Morelli C, Pinna AD, Grigioni WF. Tissue hepatitis C virus RNA quantification and protein expression help identify early hepatitis C virus recurrence after liver transplantation. Liver Transpl. 2008;14:313–20.
Vasuri F, Morelli MC, Gruppioni E, Fiorentino M, Ercolani G, Cescon M, Pinna AD, Grigioni WF, D’Errico-Grigioni A. The meaning of tissue and serum HCV RNA quantitation in hepatitis C recurrence after liver transplantation: a retrospective study. Dig Liver Dis. 2013;45:505–9.
Thung SN. Histologic findings in recurrent HBV. Liver Transpl. 2006;12:S50–3.
Duclos-Vallee JC, Sebagh M, Rifai K, Johanet C, Ballott E, Guettier C, Karam V, Hurtova M, Feray C, Reynes M, Bismuth H, Samuel D. A 10 year follow up study of patients transplanted for autoimmune hepatitis: histological recurrence precedes clinical and biochemical recurrence. Gut. 2003;52:893–7.
Khettry U, Anand N, Faul PN, Lewis WD, Pomfret EA, Pomposelli J, Jenkins RL, Gordon FD. Liver transplantation from primary biliary cirrhosis: a long-term pathologic study. Liver Transpl. 2003;9:87–96.
Randawa PS, Markin RS, Starzl TE, Demetris AJ. Epstein-Barr virus-associated syndromes in immunosuppressed liver transplant recipient. Am J Surg Pathol. 1990;14:538–47.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Vasuri, F., Malvi, D., D’Errico, A. (2015). Liver. In: Pinna, A., Ercolani, G. (eds) Abdominal Solid Organ Transplantation. Springer, Cham. https://doi.org/10.1007/978-3-319-16997-2_11
Download citation
DOI: https://doi.org/10.1007/978-3-319-16997-2_11
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-16996-5
Online ISBN: 978-3-319-16997-2
eBook Packages: MedicineMedicine (R0)